Immunotherapy with Keytruda in the Republic of Korea typically costs from AUD $7,379 to AUD $12,061 per session. Final pricing depends on the clinical tier, dosage requirements, and the specific cancer type. In Australia, this treatment costs around AUD $11,210 on average. Patients can achieve savings of approximately 34% by travelling. Fees generally cover the drug, infusion administration, and initial specialist consultations.
Bookimed Expert Insight: Choosing a university-affiliated hospital offers significant value for complex cases. Severance Hospital, for example, is certified by Joint Commission International (JCI). It uses advanced AI and digital imaging for precise monitoring. Large centres like this serve millions of patients annually. This massive volume often translates to highly refined infusion protocols. You receive world-class care that frequently appears on Newsweek’s best hospitals lists.
| Republic of Korea | Thailand | Turkey | |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $7,379 | from AUD $11,352 | from AUD $4,683 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.